Inhibition of HDAC1 suppresses pulmonary arterial remodeling, excessive ECM accumulation and the increase of RVSP and RVHI through restoring miR-34a level in MCT-induced PAH rats. Here, HDAC1 is linked to pulmonary arterial hypertension.